|
1
|
Price DT and Loscalzo J: Cellular adhesion
molecules and atherogenesis. Am J Med. 107:85–97. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cominacini L, Garbin U, Pasini AF, et al:
Antioxidants inhibit the expression of intercellular cell adhesion
molecule-1 and vascular cell adhesion molecule-1 induced by
oxidized LDL on human umbilical vein endothelial cells. Free Radic
Biol Med. 22:117–127. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jeng JR, Chang CH, Shieh SM and Chiu HC:
Oxidized low-density lipoprotein enhances monocyte-endothelial cell
binding against shear-stress-induced detachment. Biochim Biophys
Acta. 1178:221–227. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khan BV, Parthasarathy SS, Alexander RW
and Medford RM: Modified low density lipoprotein and its
constituents augment cytokine-activated vascular cell adhesion
molecule-1 gene expression in human vascular endothelial cells. J
Clin Invest. 95:1262–1270. 1995. View Article : Google Scholar
|
|
5
|
Takei A, Huang Y and Lopes-Virella MF:
Expression of adhesion molecules by human endothelial cells exposed
to oxidized low density lipoprotein. Influences of degree of
oxidation and location of oxidized LDL. Atherosclerosis. 154:79–86.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ross R: The pathogenesis of
atherosclerosis: a perspective for the 1990s. Nature. 362:801–809.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blankenberg S, Barbaux S and Tiret L:
Adhesion molecules and atherosclerosis. Atherosclerosis.
170:191–203. 2003. View Article : Google Scholar
|
|
8
|
Takahashi M, Ikeda U, Masuyama J, Kitagawa
S, Kasahara T, Shimpo M, Kano S and Shimada K: Monocyte-endothelial
cell interaction induces expression of adhesion molecules on human
umbilical cord endothelial cells. Cardiovasc Res. 32:422–429. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hansson GK: Immune mechanisms in
atherosclerosis. Arterioscler Thromb Vasc Biol. 21:1876–1890. 2001.
View Article : Google Scholar
|
|
10
|
Ikram M: A review on the chemical and
pharmacological aspects of genus Berberis. Planta Med.
28:353–358. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stermitz FR, Lorenz P, Tawara JN, Zenewicz
LA and Lewis K: Synergy in a medicinal plant: antimicrobial action
of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump
inhibitor. Proc Natl Acad Sci USA. 97:1433–1437. 2000.PubMed/NCBI
|
|
12
|
Kong W, Wei J, Abidi P, et al: Berberine
is a novel cholesterol-lowering drug working through a unique
mechanism distinct from statins. Nat Med. 10:1344–1351. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin J, Xing H and Ye J: Efficacy of
berberine in patients with type 2 diabetes mellitus. Metabolism.
57:712–717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC
and Ho TY: Berberine suppresses inflammatory agents-induced
interleukin-1beta and tumor necrosis factor-alpha productions via
the inhibition of IkappaB degradation in human lung cells.
Pharmacol Res. 56:193–201. 2007. View Article : Google Scholar
|
|
15
|
Huang Z, Wang L, Meng S, Wang Y, Chen T
and Wang C: Berberine reduces both MMP-9 and EMMPRIN expression
through prevention of p38 pathway activation in PMA-induced
macrophages. Int J Cardiol. 146:153–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsieh YS, Kuo WH, Lin TW, Chang HR, Lin
TH, Chen PN and Chu SC: Protective effects of berberine against
low-density lipoprotein (LDL) oxidation and oxidized LDL-induced
cytotoxicity on endothelial cells. J Agric Food Chem.
55:10437–10445. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pamukcu B, Lip GY, Devitt A, Griffiths H
and Shantsila E: The role of monocytes in atherosclerotic coronary
artery disease. Ann Med. 42:394–403. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mitra S, Deshmukh A, Sachdeva R, Lu J and
Mehta JL: Oxidized low-density lipoprotein and atherosclerosis
implications in antioxidant therapy. Am J Med Sci. 342:135–142.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mitra S, Goyal T and Mehta JL: Oxidized
LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther. 25:419–429.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fotis L, Agrogiannis G, Vlachos IS, et al:
Intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion
molecule (VCAM)-1 at the early stages of atherosclerosis in a rat
model. In Vivo. 26:243–250. 2012.PubMed/NCBI
|
|
21
|
Chen H, Li D, Saldeen T and Mehta JL:
Transforming growth factor-beta(1) modulates oxidatively modified
LDL-induced expression of adhesion molecules: role of LOX-1. Circ
Res. 89:1155–1160. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li D, Chen H, Romeo F, Sawamura T, Saldeen
T and Mehta JL: Statins modulate oxidized low-density
lipoprotein-mediated adhesion molecule expression in human coronary
artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther.
302:601–605. 2002. View Article : Google Scholar
|
|
23
|
Steffens S and Mach F: Inflammation and
atherosclerosis. Herz. 29:741–748. 2004. View Article : Google Scholar
|
|
24
|
Anis KV, Rajeshkumar NV and Kuttan R:
Inhibition of chemical carcinogenesis by berberine in rats and
mice. J Pharm Pharmacol. 53:763–768. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yin J, Gao Z, Liu D, Liu Z and Ye J:
Berberine improves glucose metabolism through induction of
glycolysis. Am J Physiol Endocrinol Metab. 294:E148–E156. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen FL, Yang ZH, Liu Y, et al: Berberine
inhibits the expression of TNFalpha, MCP-1 and IL-6 in
AcLDL-stimulated macrophages through PPARgamma pathway. Endocrine.
33:331–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Newby AC: Metalloproteinase expression in
monocytes and macrophages and its relationship to atherosclerotic
plaque instability. Arterioscler Thromb Vasc Biol. 28:2108–2114.
2008. View Article : Google Scholar : PubMed/NCBI
|
